Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hyster-Yale (HY) EBITDA (2016 - 2025)

Hyster-Yale's EBITDA history spans 15 years, with the latest figure at -$37.2 million for Q4 2025.

  • For Q4 2025, EBITDA fell 215.17% year-over-year to -$37.2 million; the TTM value through Dec 2025 reached -$22.1 million, down 109.03%, while the annual FY2025 figure was -$22.1 million, 109.03% down from the prior year.
  • EBITDA reached -$37.2 million in Q4 2025 per HY's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $95.6 million in Q2 2024 to a low of -$107.0 million in Q4 2021.
  • Average EBITDA over 5 years is $12.0 million, with a median of $12.8 million recorded in 2021.
  • Peak YoY movement for EBITDA: crashed 881.02% in 2021, then soared 474.52% in 2023.
  • A 5-year view of EBITDA shows it stood at -$107.0 million in 2021, then soared by 118.5% to $19.8 million in 2022, then surged by 145.96% to $48.7 million in 2023, then crashed by 33.68% to $32.3 million in 2024, then tumbled by 215.17% to -$37.2 million in 2025.
  • Per Business Quant, the three most recent readings for HY's EBITDA are -$37.2 million (Q4 2025), $2.3 million (Q3 2025), and -$8.5 million (Q2 2025).